131 related articles for article (PubMed ID: 12080326)
1. Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns.
Vuorio AF; Miettinen TA; Turtola H; Oksanen H; Gylling H
J Lab Clin Med; 2002 Jul; 140(1):35-42. PubMed ID: 12080326
[TBL] [Abstract][Full Text] [Related]
2. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.
Vuorio AF; Turtola H; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3332-7. PubMed ID: 9409330
[TBL] [Abstract][Full Text] [Related]
3. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation.
Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649
[TBL] [Abstract][Full Text] [Related]
4. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
6. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
Ketomaki A; Gylling H; Miettinen TA
J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084
[TBL] [Abstract][Full Text] [Related]
7. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia.
Ketomäki A; Gylling H; Siimes MA; Vuorio A; Miettinen TA
Pediatr Res; 2003 Apr; 53(4):648-53. PubMed ID: 12612218
[TBL] [Abstract][Full Text] [Related]
8. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion.
Koivisto PV; Miettinen TA
Lipids; 1988 Oct; 23(10):993-6. PubMed ID: 3200122
[TBL] [Abstract][Full Text] [Related]
9. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
10. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
11. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.
Narverud I; van Lennep JR; Christensen JJ; Versmissen J; Gran JM; Iversen PO; Aukrust P; Halvorsen B; Ueland T; Ulven SM; Ose L; Veierød MB; Sijbrands E; Retterstøl K; Holven KB
Atherosclerosis; 2015 Nov; 243(1):155-60. PubMed ID: 26386212
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
13. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
Kwiterovich PO
Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
[TBL] [Abstract][Full Text] [Related]
14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels.
Koivisto PV; Koivisto UM; Miettinen TA; Kontula K
Arterioscler Thromb; 1992 May; 12(5):584-92. PubMed ID: 1315570
[TBL] [Abstract][Full Text] [Related]
17. [Cholesterol concentrations in cord blood of newborn infants].
Zhao WH; Liu YJ; Shou HC; Chen LJ
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):107-9. PubMed ID: 14759310
[TBL] [Abstract][Full Text] [Related]
18. Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia.
Gylling H; Vanhanen H; Miettinen TA
J Lipid Res; 1993 Jan; 34(1):59-67. PubMed ID: 8445343
[TBL] [Abstract][Full Text] [Related]
19. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia.
Lambert M; Assouline L; Feoli-Fonseca JC; Brun N; Delvin EE; Lévy E
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):979-84. PubMed ID: 11397707
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
